Sales rise 3.35% to Rs 161.21 crore
Net profit of Lincoln Pharmaceuticals declined 4.77% to Rs 26.33 crore in the quarter ended September 2024 as against Rs 27.65 crore during the previous quarter ended September 2023. Sales rose 3.35% to Rs 161.21 crore in the quarter ended September 2024 as against Rs 155.99 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales161.21155.99 3 OPM %17.6019.97 -PBDT38.0139.45 -4 PBT34.7836.87 -6 NP26.3327.65 -5Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Russia Ukraine conflict, Russia Ukraine")
 "Stock market")
 "AUS vs PAK 1st T20 live score updates")
 "indigo airlines, indigo")
 "Spicejet")
